Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa
Anisa Mosam(University of KwaZulu-Natal), Hoosen Coovadia(University of KwaZulu-Natal), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Uvani Bodasing(University of KwaZulu-Natal), Umesh Lalloo(Wentworth Hospital), Gerald Friedland(Yale University), Jacobus P Jordaan, David T. Scadden(Harvard University), Edana Cassol(Africa Health Research Institute), Jamila Aboobaker(University of KwaZulu-Natal), Taryn Page(University of KwaZulu-Natal), Sharon Cassol(University of Pretoria), Tonya M. Esterhuizen(Stellenbosch University)
Cited by 11
Related Papers
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
|New England Journal of Medicine|2011|541